Download
1 / 8
80 likes | 89 Views
The needle-free injection system market is expected to grow from US$ 131.64 million in 2021 to US$ 411.31 million by 2028; it is estimated to grow at a CAGR of 17.7% from 2022 to 2028.<br><br>for more..<br>https://www.theinsightpartners.com/reports/needle-free-injection-system-market
E N D
Needle-Free Injection System Market Global Analysis and Forecast to 2028 Published Date : Aug 2022 Email: sales@theinsightpartners.com
Email:sales@theinsightpartners.com Report Studies • Needle-Free Injection System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Fillable Needle free Injectors and Prefilled Needle free Injectors), Technology (Jet-Based Needle free Injectors, Spring-Based Needle free Injectors, Microarray Patch Injectors, and Others), Type (Liquid-Based Needle free Injectors, Projectile-based Needle free Injectors, and Powder-Based Needle free Injectors), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others), and End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)
Email:sales@theinsightpartners.com Needle-Free Injection System Market Value CAGR of 17.7% (2022 - 2028)
Email:sales@theinsightpartners.com Needle-Free Injection System Market Overview • According to The Insight Partners research study, titled "Needle Free Injection Systems Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Technology, Type, Usability, Site of Delivery, Application, and End User," the market is expected to grow from US$ 131.64 million in 2021 to US$ 411.31 million by 2028; it is estimated to grow at a CAGR of 17.7% from 2022 to 2028. The growth of the needle free injection system market is primarily attributed to the increasing incidence of communicable diseases due to needlestick injuries (NSIs) and the advantages of using self-injection devices. However, higher development costs of needle free injectors compared to conventional injection systems are hindering the growth of the market.
Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product (Fillable Needle free Injectors and Prefilled Needle free Injectors) • By Technology (Jet-Based Needle free Injectors, Spring-Based Needle free Injectors, Microarray Patch Injectors, and Others) • By Type (Liquid-Based Needle free Injectors, Projectile-based Needle free Injectors, and Powder-Based Needle free Injectors) • By Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors) • By Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others) • By End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)
Email:sales@theinsightpartners.com Company Profiles • Crossject • INOVIO Pharmaceuticals • Zealand Pharma A/S • PharmaJet • Portal Instruments • Medical International Technologies (MIT Canada) Inc. • NuGen Medical Devices • Ferring B.V. • National Medical Products, Inc. • Aijex Pharma International Inc. Download Sample Here
Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).
THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com
